Advance on anti-tumor theranostics and biosafety of bismuth-based nanomedicine / 药学学报
Acta Pharmaceutica Sinica
; (12): 852-855, 2023.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-978754
Responsible library:
WPRO
ABSTRACT
Nanomedicine is one of the most promising fields in biomedicine. Inorganic nanomaterials stand out among many nanomaterials due to their excellent physicochemical properties, stable chemical properties and high biocompatibility. As an inorganic nanomaterial, bismuth-based nanomaterials have the advantages of adjustable band gap, low toxicity, easy functionalization, large X-ray attenuation coefficient, high photothermal conversion efficiency and long cycle half-life, so they have good promising application in cancer diagnosis and treatment. This review summarizes the recent research progress of bismuth-based nanomaterials in tumor diagnosis, treatment and biosafety, which provides a theoretical basis for the design and exploitation of a new generation of bismuth-based nanomedicine systems.
Full text:
Available
Health context:
SDG3 - Target 3D Strengthen the capacity for early warning, risk reduction and management of national and global health risks
Health problem:
Biological Hazards
Database:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Acta Pharmaceutica Sinica
Year:
2023
Document type:
Article